Gustav A. Horn

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.

Aesculap AG engages in the development, manufacture, and distribution of precision, medical, as well as medical technology instruments. It also offers medical apparatus, prostheses, implants, suture materials, laboratory and hospital supplies, as well as equipment for the manufacture of medical and medical technology devices. The company was founded in 1867 and is headquartered in Tuttlingen, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

The Max Planck Institute for the Study of Societies engages in research on the governance of modern societies. The private company is based in Cologne, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.